A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations

Human Molecular Genetics

Volumn 23, Issue 8, 2014, Pages 2210-2219

  Pan, Liping ^a   Zhang, Li ^b   Zhang, Wei ^c   Wu, Xiaopan ^a   Li, Yuanfeng ^d   Yan, Bingyu ^b   Zhu, Xilin ^a   Liu, Xing ^a   Yang, Chao ^a   Xu, Jianfeng ^e   Zhou, Gangqiao ^d   Xu, Aiqiang ^b   Li, Hui ^a   Liu, Ying ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; BTNL2 ANTIGEN; C6ORF10 ANTIGEN; HEPATITIS B VACCINE; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ANTIBODY TITER; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEPATITIS B; HEREDITY; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; VACCINATION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; FOLLOW-UP STUDIES; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HAPLOTYPES; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HLA-DR ANTIGENS; HUMANS; MALE; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROGNOSIS; VACCINATION;

EID: 84897840405     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt586     Document Type: Article

References (45)

1. Lai, C.L. and Yuen, M.F. (2008) Chronic hepatitis B - new goals, new treatment. N. Engl. J. Med., 359, 2488-2491.
2. Shepard, C.W., Simard, E.P., Finelli, L., Fiore, A.E. and Bell, B.P. (2006) Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev., 28, 112-125.
3. Custer, B., Sullivan, S.D., Hazlet, T.K., Iloeje, U., Veenstra, D.L. and Kowdley, K.V. (2004) Global epidemiology of hepatitis B virus. J. Clin. Gastroenterol., 38, S158-S168.
4. Lu, F.M. and Zhuang, H. (2009) Prevention of hepatitis B in China: achievements and challenges. Chin. Med. J. (Engl.), 122, 2925-2927.
5. Zuckerman, J.N. (1996) Nonresponse to hepatitisB vaccines and the kinetics of anti-HBs production. J. Med. Virol., 50, 283-288.
6. Boland, G.J., van Bommel, T., Rulos-van den Berg, A., van den Berg, J.P., van Loon, A.M. and van Hattum, J. (2003) The efficacy of a two-dose hepatitis B vaccination scheme. Adv. Exp. Med. Biol., 531, 185-190.
7. Hollinger, F.B. (1989) Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am. J. Med., 87, 36S-40S.
8. Weber, D.J., Rutala, W.A., Samsa, G.P., Santimaw, J.E. and Lemon, S.M. (1985) Obesity as a predictor of poor antibody response to hepatitisB plasma vaccine. JAMA, 254, 3187-3189.
9. Wood, R.C., MacDonald, K.L., White, K.E., Hedberg, C.W., Hanson, M. and Osterholm, M.T. (1993) Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA, 270, 2935-2939.
10. Barraclough, K.A., Wiggins, K.J., Hawley, C.M., van Eps, C.L., Mudge, D.W., Johnson, D.W., Whitby, M., Carpenter, S. and Playford, E.G. (2009) Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination. Am. J. Kidney Dis., 54, 95-103.
11. Jafarzadeh, A., Zarei, S. and Shokri, F. (2008) Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates. Vaccine, 26, 269-276.
12. Zhuang, G.H., Yan, H., Wang, X.L., Hwang, L.Y., Wu, Q., Wang, L.R. and Gao, H.Y. (2006) Hepatitis B revaccination in healthy non-responder Chinese children: five-year follow-up of immuneresponse and immunologic memory. Vaccine, 24, 2186-2192.
13. Newport, M.J., Goetghebuer, T., Weiss, H.A., Whittle, H., Siegrist, C.A. and Marchant, A. (2004) Genetic regulation of immune responses to vaccines in early life. Genes Immun., 5, 122-129.
14. Chen, J., Liang, Z., Lu, F., Fang, X., Liu, S., Zeng, Y., Zhu, F., Chen, X., Shen, T., Li, J. et al. (2010) Toll-like receptors and cytokines/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine, 29, 706-711.
15. Davila, S., Froeling, F.E., Tan, A., Bonnard, C., Boland, G.J., Snippe, H., Hibberd, M.L. and Seielstad, M. (2010) Newgenetic associations detected in a host response study to hepatitis B vaccine. Genes Immun., 11, 232-238.
16. Godkin, A., Davenport, M. and Hill, A.V. (2005) Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology, 41, 1383-1390.
17. Pan, L., Zhang, W., Liang, Z., Wu, X., Zhu, X., Li, J., Li, T., Wang, L., Li, H. and Liu, Y. (2012) Association between polymorphisms of the cytokine and cytokine receptor genes and immune response to hepatitis B vaccination in a Chinese Han population. J. Med. Virol., 84, 26-33.
18. Wang, C., Tang, J., Song, W., Lobashevsky, E., Wilson, C.M. and Kaslow, R.A. (2004) HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology, 39, 978-988.
19. Yucesoy, B., Sleijffers, A., Kashon, M., Garssen, J., de Gruijl, F.R., Boland, G.J., van Hattum, J., Simeonova, P.P., Luster, M.I. and van Loveren, H. (2002) IL-1beta gene polymorphisms influence hepatitis B vaccination. Vaccine, 20, 3193-3196.
20. Pan, L.P., Zhang, W., Zhang, L., Wu, X.P., Zhu, X.L., Yan, B.Y., Li, J.Y., Xu, A.Q., Liu, Y. and Li, H. (2012) CD3Z genetic polymorphism in immune response to hepatitisB vaccination in two independent Chinese populations. PLoS ONE, 7, e35303.
21. Zondervan, K.T. and Cardon, L.R. (2007) Designing candidate gene and genome-wide case-control association studies. Nat. Protoc., 2, 2492-2501.
22. Png, E., Thalamuthu, A., Ong, R.T., Snippe, H., Boland, G.J. and Seielstad, M. (2011) A genome-wide association study of hepatitis B vaccine response in an Indonesian population reveals multiple independent risk variants in the HLA region. Hum. Mol. Genet., 20, 3893-3898.
23. WHO. (1992) Informal Consultation on Quadrivalent Diphtheria-Tetanus-Pertussis-Hepatitis B Vaccine: Final Report. World Health Organization, Geneva.
24. Hohler, T., Reuss, E., Evers, N., Dietrich, E., Rittner, C., Freitag, C.M., Vollmar, J., Schneider, P.M. and Fimmers, R. (2002) Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus: a vaccination study in twins. Lancet, 360, 991-995.
25. Li, Y., Ni, R., Song, W., Shao, W., Shrestha, S., Ahmad, S., Cunningham, C.K., Flynn, P.M., Kapogiannis, B.G., Wilson, C.M. et al. (2009) Clear and independent associations of several HLA-DRB1 alleles with differential antibody responses to hepatitis B vaccination in youth. Hum. Genet., 126, 685-696.
26. Kimman, T.G., Vandebriel, R.J. and Hoebee, B. (2007) Genetic variation in the response to vaccination. Commun. Genet., 10, 201-217.
27. Milich, D.R. (1988) T- and B-cell recognition of hepatitis B viral antigens. Immunol. Today, 9, 380-386.
28. Kruger, A., Adams, P., Hammer, J., Bocher, W.O., Schneider, P.M., Rittner, C. and Hoehler, T. (2005) Hepatitis B surface antigen presentation and HLA-DRB1*-lessons from twins and peptide binding studies. Clin. Exp. Immunol., 140, 325-332.
29. Ovsyannikova, I.G. and Poland, G.A. (2011) Vaccinomics: current findings, challenges and novel approaches for vaccine development. AAPS J., 13, 438-444.
30. Poland, G.A., Ovsyannikova, I.G., Jacobson, R.M. and Smith, D.I. (2007) Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics. Clin. Pharmacol. Ther., 82, 653-664.
31. Yucesoy, B., Johnson, V.J., Fluharty, K., Kashon, M.L., Slaven, J.E., Wilson, N.W., Weissman, D.N., Biagini, R.E., Germolec, D.R. and Luster, M.I. (2009) Influence of cytokine gene variations on immunization to childhood vaccines. Vaccine, 27, 6991-6997.
32. Zuckerman, J.N. (2006) Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J. Med. Virol., 78, 169-177.
33. Kamatani, Y., Wattanapokayakit, S., Ochi, H., Kawaguchi, T., Takahashi, A., Hosono, N., Kubo, M., Tsunoda, T., Kamatani, N., Kumada, H. et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet., 41, 591-595.
34. Mbarek, H., Ochi, H., Urabe, Y., Kumar, V., Kubo, M., Hosono, N., Takahashi, A., Kamatani, Y., Miki, D., Abe, H. et al. (2011) Agenome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet., 20, 3884-3892.
35. Nishida, N., Sawai, H., Matsuura, K., Sugiyama, M., Ahn, S.H., Park, J.Y., Hige, S., Kang, J.H., Suzuki, K., Kurosaki, M. et al. (2012) Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean. PLoS ONE, 7, e39175.
36. Kim, Y.-J., Kim, H.Y., Lee, J.-H., Yu, S.J., Yoon, J.-H., Lee, H.-S., Kim, C.Y., Cheong, J.Y., Cho, S.W., Park, N.H. et al. (2013) Genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum. Mol. Genet., 22, 4233-4238.
37. Jiang, D.K., Sun, J., Cao, G., Liu, Y., Lin, D., Gao, Y.Z., Ren, W.H., Long, X.D., Zhang, H., Ma, X.P. et al. (2013) Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat. Genet., 45, 72-75.
38. Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.X., Foo, J.N., McLaren, P.J., Li, Z., Yang, J. et al. (2012) GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet., 8, e1002791.
39. Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W. et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet., 42, 755-758.
40. Clemens, R., Sanger, R., Kruppenbacher, J., Hobel, W., Stanbury, W., Bock, H.L. and Jilg, W. (1997) Booster immunization of low- and non-responders after a standard three dose hepatitis B vaccine schedule - results of a post-marketing surveillance. Vaccine, 15, 349-352.
41. Shokri, F. and Amani, A. (1997) High rate of seroconversion following administration of a single supplementary dose of recombinant hepatitis B vaccine in Iranian healthy nonresponder neonates. Med. Microbiol. Immunol., 185, 231-235.
42. Zhang, F.R., Huang, W., Chen, S.M., Sun, L.D., Liu, H., Li, Y., Cui, Y., Yan, X.X., Yang, H.T., Yang, R.D. et al. (2009) Genomewide association study of leprosy. N. Engl. J. Med., 361, 2609-2618.
43. Pruim, R.J., Welch, R.P., Sanna, S., Teslovich, T.M., Chines, P.S., Gliedt, T.P., Boehnke, M., Abecasis, G.R. and Willer, C.J. (2010) LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics, 26, 2336-2337.
44. Yang, J., Lee, S.H., Goddard, M.E. and Visscher, P.M. (2011) GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet., 88, 76-82.
45. Shi, Y.Y. and He, L. (2005) SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res., 15, 97-98.